Role of chronic hypoxia and hypoxia inducible factor in kidney disease

Chinese Medical Journal

Volumn 121, Issue 3, 2008, Pages 257-264

  Nangaku, Masaomi ^a   Nishi, Hiroshi ^a   Miyata, Toshio ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin; Chronic kidney disease; Hypoxia inducible factor; Ischemia; Prolyl hydroxylases

Indexed keywords

ADENOVIRUS VECTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; CARBON MONOXIDE; COBALT CHLORIDE; DEFEROXAMINE; ETHYL 3,4 DIHYDROXYBENZOATE; FG 4487; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IRON CHELATING AGENT; MESSENGER RNA; MIMOSINE; NITRIC OXIDE; OXYGENASE INHIBITOR; PLACEBO; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TEMPOL; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN; XANTHINE OXIDASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG EFFICACY; DRUG TARGETING; DRUG TOLERABILITY; ENERGY METABOLISM; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE TRANSFER; GLOMERULONEPHRITIS; HUMAN; HYPOXEMIA; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY METABOLISM; LIMB ISCHEMIA; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET TRANSPLANTATION; PATHOGENESIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; TISSUE OXYGENATION; VIRAL GENE THERAPY;

EID: 39049135878     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200802010-00015     Document Type: Article

References (71)

1. Bastin J, Cambon N, Thompson M, Lowry OH, Burch HB. Change in different segments of the nephron during brief ischemia. Kidney Int 1987; 31: 1239-1247.
2. Eddy AA. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 1994; 5: 1273-1287.
3. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med 2004; 43: 9-17.
4. Nangaku M. Final common pathways of progression of renal diseases. Clin Exp Nephrol 2002; 6: 182-189.
5. Eckardt KU, Bernhardt WM, Weidemann A, Warnecke C, Rosenberger C, Wiesener MS, et al. Role of hypoxia in the pathogenesis of renal disease. Kidney Int 2005; 99 Suppl: s46-s51.
6. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17: 17-25.
7. Nangaku M. Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. Nephron Exp Nephrol 2004; 98: E8-E12.
8. Wang GL, Semenza, GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 1993; 90: 4304-4308.
9. Semenza GL. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 2004; 19: 176-182.
10. Tian H, McKnight SL, Russell DW. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 1997; 11: 72-82.
11. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, Fujii-Kuriyama Y, A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci U S A 1997; 94: 4273-4278.
12. Wiesener MS, Jurgensen JS, Rosenberger C, Scholze CK, Horstrup JH, Warnecke C, et al. Widespread hypoxia-inducible expression of HIF-2 alpha in distinct cell populations of different organs. FASEB J 2003; 17: 271-273.
13. Warnecke C, Griethe W, Weidemann A, Jurgensen JS, Willam C, Bachmann S, et al. Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors. FASEB J 2003; 17: 1186-1188.
14. Morita M, Ohneda O, Yamashita T, Takahashi S, Suzuki N, Nakajima O, et al. HLF/HIF-2 alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J 2003; 22: 1134-1146.
15. Gruber M, Hu CJ, Johnson RS, Brown EJ, Keith B, Simon MC. Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci U S A 2006; 104: 2301-2306.
16. Rankin EB, Biju MP, Liu Q, Unger TL, Rha J, Johnson RS, et al. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 2007; 117: 1068-1077.
17. Rosenberger C, Mandriota S, Jurgensen JS, Wiesener MS, Horstrup JH, Frei U, et al. Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol. 2002; 13: 1721-1732.
18. Makino Y, Cao R, Svensson K, Bertilsson G, Asman M, Tanaka H, et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 2001; 414: 550-554.
19. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, et al. C elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107: 43-54.
20. 2 sensing. Science 2001; 292: 464-468.
21. Myllyfiarju J. Prolyl 4-hydroxylases, the key, enzymes of collagen biosynthesis. Matrix Biol 2003; 22: 15-24.
22. Lieb ME, Menzies K, Moschella MC, Ni R, Taubman MB. Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem Cell Biol 2002; 80: 421-426.
23. Appelhoff RJ, Tian. YM, Raval RR, Turley H, Harris AL, Pugh CW, et al. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 2004; 279: 38458-38465.
24. Takeda K, Cowan A, Fong GH. Essential role for prolyl hydroxylase-domain protein 2 oxygen homeostasis of the adult vascular system. Circulation 2007; 116: 774-781.
25. Percy MJ, Zhao Q, Flores A, Harrison C, Lappin TR, Maxwell PH, et al. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc Natl Acad Sci U S A 2006; 103; 654-659.
26. Li N, Yi F, Sundy CM, Chen L, Hilliker ML, Donley DK, et al. Expression and actions of HIF prolyl-hydroxylase in the rat kidneys. Am J Physiol Renal Physiol 2007; 292: F207-F216.
27. Koivumen P, Tiainen P, Hyvarinen J, Williams KE, Sormunen R, Klaus SJ, et al. Arr endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on HIF-alpha. J Biol Chem 2007; 282: 30544-30552.
28. Mahon PC, Hirota K, Semenza GL. FIH-1: a novel protein that interacts with HIF-1Alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 2001; 15: 2675-2686.
29. Matsumoto M, Tanaka T, Yamamoto T, Noiri E, Miyata T, Inagi R, et al. Hypoperfusion of peritubular capillaries induced chronic hypoxia prior to progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J Am Soc Nephrol 2004; 15: 1574-1581.
30. Bernhardt WM, Wiesener MS, Weidemann A, Schmitt R, Weichert W, Lechler P, et al. Involvement of hypoxia-inducible transcription factors in polycystic kidney disease. Am J Pathol 2007; 170. 830-842.
31. Izuhara Y, Nangaku M, Inagi R, Tominaga N, Aizawa T, Kurokawa K, et al. Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol 2005; 16: 3631-3641.
32. Palm F, Cederberg J, Hartsell P, Liss P, Carlsson PO. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 2003; 46: 1153-1160.
33. Palm F, Hansell P, Ronquist G, Waldenstrom A, Liss P, Carlsson PO. Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats. Diabetologia, 2004; 47: 1223-1231.
34. Palm F, Ortsater H, Hansell P, Liss P, Carlsson PO. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in thb streptozotocin-diabetic rat model. Diabetes Metab Res Rev 2004; 20: 452-459.
35. Welch WJ, Baumgartl H, Lubbers D, Wilcox CS. Renal oxygenation defects in the spontaneously hypertensive rat: role of AT1 receptors. Kidney Int 2003; 63: 202-208.
36. Welch WJ, Mendonca M, Aslam S, Wilcox CS. Roles of oxidative stress and AT1 receptors in renal hemodynamics and oxygenation in the postclipped 2K, 1C kidney. Hypertension 2003; 41: 692-696.
37. Ries M, Basseau F, Tyndal B, Jones R, Deminiere C, Catargi B, et al. Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Reson Imaging 2003; 17: 104-113.
38. Tanaka T, Miyata T, Inagi R, Fujita T, Nangaku M. Hypoxia in renal disease with proteinuria and/or glomerular hypertension. Am J Pathol 2004; 165: 1979-1992.
39. Tanaka T, Kato H, Kojima I, Ohse T, Son D, Kawakami T, et al. Hypoxia and expression of hypoxia-inducible factor in the aging kidney. J Gerontol A Biol Sci Med Sci 2006; 61A: 795-805.
40. Safran M, Kim WY, O'Connell F, Flippin L. Gunzler V, Homer JW, et al. Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. Proc Natl Acad Sci U S A 2006; 103: 105-110.
41. Kairaitis LK, Wang Y, Gassmann M, Tay YC, Harris DC. HIF-1 expression follows microvascular loss in advanced murine adriamycin nephrosis. Am J Physiol Renal Physiol 2005; 288: F198-F206.
42. Namikoshi T, Satoh M, Horike H, Fujimoto S, Arakawa S, Sasaki T, et al. Implication of peritubular capillary loss and altered expression of vascular endothelial growth factor in IgA nephropathy. Nephron Physiol 2006; 102: 9-16.
43. Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001; 281: F887-F899.
44. Rabelink TJ, Wijewickrama DC, de Koning EJ. Peritubular endothelium: the achilles heel of the kidney? Kidney Int 2007; 72: 926-930.
45. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal Renin-Angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59: 251-287.
46. Kondo N, Kiyomoto H, Yamamoto T, Miyatake A, Sun GP, Rahman M, et al. Effects of calcium channel blockade on angiotensin II-induced peritubular ischemia in rats. J Pharmacol Exp Ther 2006; 316: 1047-1052.
47. Schachinger H, Klarhofer M, Linder L, Drewe J. Scheffler K. Angiotensin II decreases the renal MRI blood oxygenation level-dependent signal. Hypertension 2006; 47: 1062-1066.
48. Welch WJ, Blau J, Xie H, Chabrashvili T, Wilcox CS. Angiotensin-induced defects in renal oxygenation: role of oxidative stress. Am J Physiol Heart Circ Physiol 2005; 288: H22-H28.
49. Nangaku M, Fujita T. Activation of the renim-angiotensin system and chronic hypoxia of the kidney. Hypertens Res 2008: in press.
50. Palm F, Buerk DG, Carlsson PO, Hansell P, Liss P. Reduced nitric oxide concentration in the renal cortex of streptozotocin-induced diabetic rats: effects on renal oxygenation and microcirculation. Diabetes 2005; 54: 3282-3287.
51. Abramov AY, Scorziello A, Duchen MR. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurose 2007; 27: 1129-1138.
52. Son D, Kojima I, Inagi R, Matsumoto M, Fujita T, Nangaku M. Chronic hypoxia aggravates renal injury via suppression of Cu/Zn-SOD - a proteornic analysis. Am J Physiol Renal Physiol 2007: e-Pub.
53. Nangaku M, Fliser D. Erythropoiesis-stimulating agents: past and future, Kidney Int 2007; 107: 1-3.
54. Nangaku M, Eckardt KU. Pathogenesis of renal anemia. Semin Nephrol 2006; 26. 261-268.
55. Tanaka T, Miyata T, Inagi R, Kurokawa K, Adler S, Fujita T, et al. Hypoxia-induced apoptosis in cultured glomerular endothelial cells: involvement of mitochondrial pathways. Kidney Int 2003; 64: 1020-2032.
56. Manotham K, Tanaka T, Matsumoto M, Ohse T, Inagi R, Miyata T, et al. Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int 2004; 65: 871-880.
57. Norman JT, Orphanides C, Garcia P, Fine LG Hypoxia-induced changes in extracellular matrix metabolism in renal cells. Exp Nephrol 1999; 7: 463-469.
58. 2 indicating a novel, potentially renoprotective action. Nephron Physiol 2003, 94: 39-46.
59. Manotham K, Tanaka T, Matsumoto M, Ohse T, Miyata T, Inagi R, et al. Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol 2004; 15: 1277-1288.
60. Manotham K, Tanaka T, Ohse, T, Kojima I, Miyata T, Inagi R, et al. A biologic role of HIF-1 in the renal medulla. Kidney Int 2005; 67: 1428-1439.
61. Rajagopalan S, Olin J, Deitcher S, Pieczek A, Laird J, Grossman PM, et al. Use of a constitatively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience. Circulation 2007; 115: 1234-1243.
62. Matsumoto M, Makino Y, Tanaka T, Tanaka H, Ishizaka N, Noiri E, et al. Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol 2003; 14: 1825-1832.
63. Bernhardt WM, Campean V, Kany S, Juergensen JS, Weidemann A, Warnecke C, et al. Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure. J Am Soc Nephrol 2006; 17: 1970-1978.
64. Tanaka T, Kojima I, Ohse T, Inagi R, Miyata T, Ingelfinger JR, et al. Hypoxia-inducible factor modulates tubular cell survival in cisplatin nephrotoxicity. Am J Physiol Renal Physiol 2005; 289: F1123-F1133.
65. Weidemann A, BW, Klanke B, Daniel C, Buchholz B, Campean V, et al. HIF-activation protects-from cisplatin-induced acute toxic kidney injury. J Am Soc Nephrol 2008: in press.
66. Kudo Y, Kakinuma Y, Mori Y, Morimoto, N, Karashima T, Furihata M, et al. Hypoxia-inducible factor-1alpha is involved in the attenuation of experimentally induced rat glomerulonephritis. Nephron Exp Nephrol 2005; 100: e95-e103.
67. Tanaka T, Matsumoto M, Inagi R, Miyata T, Kojima I, Ohse T, et al. Induction of protective genes by cobalt ameliorates tabulointerstitial injury in the progressive Thy1 nephritis Kidney Int 2005; 68: 2714-2725.
68. Tanaka T, Kojima I, Ohse T, Ingelfinger JR, Adler Fujita T, et al. Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model. Lab Invest 2005; 85: 1292-1307.
69. Ohtomo S, Nangaku M, Izuhara Y, van Ypersele de Strihou C, Miyata T. Induction of hypoxia inducible factor (HIF)-regulated genes by cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model. Nephrol Dial Transplant 2007; e-Pub.
70. Nangaku M, Kojima I, Tanaka T, Ohse T, Kato H, Fujita T. Novel drugs and the response to hypoxia: HIF stabilizers and prolyl hydroxylase. Recent Patent Rev Cardiovasc; Drug Disc 2006; 1: 129-1391.
71. Nangaku M, Izuhara Y, Takizawa S, Yamashita, T, Fujii-Kuriyama Y, Ohneda O, et al. A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia. Arterioscler Thromb Vasc Biol 2007; 27: 2548-2554.